BMAL1 and Parkinson disease: Several studies have reported lower levels and dampened melatonin oscillation and a lack of time-dependent variation in BMAL1 expression in PD patients, compared to healthy controls, indicating that the peripheral molecular clock is affected in PD [109,211,226].